CompletedNot Applicable

Comparison of CorWatch With Right Heart Catheter Measurements in Heart Failure

United States43 participantsStarted 2021-08-01

Plain-language summary

This is an observational study to evaluate the agreement between the InCardia diagnostic technology CorWatch for the assessment of venous pressure in human subjects. This includes evaluation of InCardia technology in heart failure (HF) patients undergoing invasive right heart catheterization in a cardiac catheterization laboratory (cath lab) and in a cardiac intensive care unit (ICU).

Who can participate

Age range21 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed with NYHA class II-IV heart failure irrespective of ejection fraction * Patient is able to give consent Exclusion Criteria: * Severe tricuspid regurgitation * Mechanical ventilation * Patient is pregnant * Inability to access either of the patient's upper arms.

What they're measuring

Agreement with right atrial pressure as measured by Swan Ganz catheter

Timeframe: During the right heart catheterization procedure

Trial details

NCT IDNCT04928326

SponsorInCardia Inc.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2022-09-01

View on ClinicalTrials.gov More Heart Failure trials